Petrello A, Yared J, Onukwugha E, Slejko JF.

Trends in Stem Cell Transplant in Elderly Medicare Beneficiaries with Multiple Myeloma in the United States

 

Slejko JF, Rueda JD, Trovato JA, Gorman EF, Betz G, Arcona S, Zacker C, Stuart B

Measuring Oral Oncolytic Dose Intensity using Pharmacy Claims Data

AMCP Nexus. October 22-25, 2018, Orlando, FL.

 

Gordon C, Gray C, Mahler JA, Rueda JD, Slejko JF

THE EFFECT OF GENERIC STATIN AVAILABILITY ON INITIAL STATIN PRESCRIBING TRENDS AMONG MEDICARE BENEFICIARIES

ISPOR 23rd Annual International Meeting. May 20-24, 2018. Baltimore, MD.

 

Mahler JA, Gordon C, Gray C, Rueda JD, Slejko JF

Initial High-Intensity Statin Prescribing among Elderly Medicare Beneficiaries in the Context of the 2013 ACC/AHA Guideline Update

AMCP Managed Care & Specialty Pharmacy Annual Meeting. April 23-26, 2018. Boston, MA.

 

Onwudiwe NC, Slejko JF, Mattingly J, Levy JF.

TRANSFERABILITY OF ECONOMIC EVALUATION STUDIES: IS THERE A GENERALLY ACCEPTED ALTERNATIVE PRICE BENCHMARK TO THE WAC PRICE? (Invited Workshop)

Slides Part 1

Slides Part 2

ISPOR 22nd Annual International Meeting. May 20-24, 2017. Boston, MA.

 

Slejko JF, Rueda JD, Cooke CE, Shen X, Ciarametaro M, Dubois RW, Stuart B

ASSESSING THE EFFECT OF FORMULARY RESTRICTIONS ON ANTIHYPERGLYCEMIC DRUGS

ISPOR 21st Annual International Meeting. May 21-25, 2016. Washington, DC.

 

Rueda JD, Slejko JF, Cooke C, Shen X, Ciarametaro M, Dubois R, Stuart B.

Building the Evidence Base for Evaluating Complex Formulary Designs in Type 2 Diabetes Mellitus

2016 Annual Research Meeting, June 26-28, 2016. Boston, MA.